These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30857745)

  • 21. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
    Alonso-Coello P; Schünemann HJ; Moberg J; Brignardello-Petersen R; Akl EA; Davoli M; Treweek S; Mustafa RA; Rada G; Rosenbaum S; Morelli A; Guyatt GH; Oxman AD;
    BMJ; 2016 Jun; 353():i2016. PubMed ID: 27353417
    [No Abstract]   [Full Text] [Related]  

  • 22. Defining decision thresholds for judgments on health benefits and harms using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks: a protocol for a randomised methodological study (GRADE-THRESHOLD).
    Morgano GP; Mbuagbaw L; Santesso N; Xie F; Brozek JL; Siebert U; Bognanni A; Wiercioch W; Piggott T; Darzi AJ; Akl EA; Verstijnen IM; Parmelli E; Saz-Parkinson Z; Alonso-Coello P; Schünemann HJ
    BMJ Open; 2022 Mar; 12(3):e053246. PubMed ID: 35273045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardized wording to improve efficiency and clarity of GRADE EtD frameworks in health guidelines.
    Piggott T; Baldeh T; Dietl B; Wiercoch W; Nieuwlaat R; Santesso N; Coello PA; Schünemann HJ
    J Clin Epidemiol; 2022 Jun; 146():106-122. PubMed ID: 35041970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines that use the GRADE approach often fail to provide complete economic information for recommendations: A systematic survey.
    Riva JJ; Bhatt M; Brunarski DJ; Busse JW; Martins CC; Xie F; Schünemann HJ; Brozek JL
    J Clin Epidemiol; 2021 Aug; 136():203-215. PubMed ID: 33984495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.
    Zhang Y; Coello PA; Brożek J; Wiercioch W; Etxeandia-Ikobaltzeta I; Akl EA; Meerpohl JJ; Alhazzani W; Carrasco-Labra A; Morgan RL; Mustafa RA; Riva JJ; Moore A; Yepes-Nuñez JJ; Cuello-Garcia C; AlRayees Z; Manja V; Falavigna M; Neumann I; Brignardello-Petersen R; Santesso N; Rochwerg B; Darzi A; Rojas MX; Adi Y; Bollig C; Waziry R; Schünemann HJ
    Health Qual Life Outcomes; 2017 May; 15(1):52. PubMed ID: 28460638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Schünemann HJ; Oxman AD; Akl EA; Brozek JL; Montori VM; Heffner J; Hill S; Woodhead M; Campos-Outcalt D; Alderson P; Woitalla T; Puhan MA; Falck-Ytter Y; Bousquet J; Guyatt G;
    Proc Am Thorac Soc; 2012 Dec; 9(5):282-92. PubMed ID: 23256172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using GRADE Evidence to Decision frameworks to support the process of health policy-making: an example application regarding taxation of sugar-sweetened beverages.
    Stadelmaier J; Rehfuess EA; Forberger S; Eisele-Metzger A; Nagavci B; Schünemann HJ; Meerpohl JJ; Schwingshackl L
    Eur J Public Health; 2022 Nov; 32(Suppl 4):iv92-iv100. PubMed ID: 36444109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Making the GRADE in anaphylaxis management: Toward recommendations integrating values, preferences, context, and shared decision making.
    Shaker MS; Oppenheimer J; Wallace DV; Golden DBK; Lang DM; ; ; Lang ES; Bernstein JA; Campbell RL; Chu D; Dinakar C; Ellis AK; Greenhawt M; Horner C; Lieberman JA; Rank MA; Stukus DR; Wang J
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):526-535.e2. PubMed ID: 32199979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations.
    Meneses-Echavez JF; Bidonde J; Montesinos-Guevara C; Amer YS; Loaiza-Betancur AF; Tellez Tinjaca LA; Fraile Navarro D; Poklepović Peričić T; Tokalić R; Bala MM; Storman D; Swierz M; Zając J; Flórez ID; Schünemann H; Flottorp S; Alonso-Coello P
    J Clin Epidemiol; 2023 Oct; 162():38-46. PubMed ID: 37517506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Integrative assessment of evidence in healthcare: the GRADE system].
    Schünemann H
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(5):261-8. PubMed ID: 19645339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodology for the development of the NHF-McMaster Guideline on Care Models for Haemophilia Management.
    Pai M; Santesso N; Yeung CH; Lane SJ; Schünemann HJ; Iorio A
    Haemophilia; 2016 Jul; 22 Suppl 3():17-22. PubMed ID: 27348397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualitative Evidence Synthesis (QES) for Guidelines: Paper 3 - Using qualitative evidence syntheses to develop implementation considerations and inform implementation processes.
    Glenton C; Lewin S; Lawrie TA; Barreix M; Downe S; Finlayson KW; Tamrat T; Rosenbaum S; Tunçalp Ö
    Health Res Policy Syst; 2019 Aug; 17(1):74. PubMed ID: 31391071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach.
    Neumann I; Santesso N; Akl EA; Rind DM; Vandvik PO; Alonso-Coello P; Agoritsas T; Mustafa RA; Alexander PE; Schünemann H; Guyatt GH
    J Clin Epidemiol; 2016 Apr; 72():45-55. PubMed ID: 26772609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Informing the GRADE evidence to decision process with health equity considerations: demonstration from the Canadian rheumatoid arthritis care context.
    Barnabe C; Pianarosa E; Hazlewood G
    J Clin Epidemiol; 2021 Oct; 138():147-155. PubMed ID: 34161803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions.
    Dahm P; Oxman AD; Djulbegovic B; Guyatt GH; Murad MH; Amato L; Parmelli E; Davoli M; Morgan RL; Mustafa RA; Sultan S; Falck-Ytter Y; Akl EA; Schünemann HJ
    J Clin Epidemiol; 2017 Jun; 86():129-139. PubMed ID: 28377194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indirectness (transferability) is critical when considering existing economic evaluations for GRADE clinical practice guidelines: a systematic review.
    Riva JJ; Bhatt M; Martins CC; Brunarski DJ; Busse JW; Xie F; Schünemann HJ; Brozek JL
    J Clin Epidemiol; 2022 Aug; 148():81-92. PubMed ID: 35462047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decision-making frameworks and considerations for informing coverage decisions for healthcare interventions: a critical interpretive synthesis.
    Morgan RL; Kelley L; Guyatt GH; Johnson A; Lavis JN
    J Clin Epidemiol; 2018 Feb; 94():143-150. PubMed ID: 28988959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.